Helmut Albrecht to Antiretroviral Therapy, Highly Active
This is a "connection" page, showing publications Helmut Albrecht has written about Antiretroviral Therapy, Highly Active.
Connection Strength
0.280
-
The South Carolina HIV Cascade of Care. South Med J. 2015 Nov; 108(11):670-4.
Score: 0.124
-
Early correction of cell cycle perturbations predicts the immunological response to therapy in HIV-infected patients. AIDS. 2004 Feb 20; 18(3):393-402.
Score: 0.055
-
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial. Lancet HIV. 2019 06; 6(6):e364-e372.
Score: 0.039
-
The South Carolina rural-urban HIV continuum of care. AIDS Care. 2017 07; 29(7):817-822.
Score: 0.033
-
Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults. Clin Cardiol. 2014 Sep; 37(9):517-22.
Score: 0.029